Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Dr Lal Pathlabs Ltd

Healthcare | Small Cap

Dr Lal Pathlabs Ltd Health Insights
Health Score : 8.79Health Score : 8.79

Dr Lal Pathlabs Ltd. demonstrates exceptional financial health, characterized by outstanding profitability and robust growth. The company is highly effective at turning revenue into profit and is expanding its earnings and sales at an impressive rate. Its financial foundation is remarkably strong, with very low reliance on debt, which minimizes financial risk. The company also maintains a very strong capacity to cover its immediate financial obligations. A key area of mixed performance is in its operational efficiency; while it manages its inventory and customer payments very effectively, it is not generating as much sales from its long-term assets as it could be. There is also a potential concern regarding the sustainability of its dividend payments, as earnings do not appear to fully cover them. Overall, the company's strong profitability and growth paint a positive picture, supported by a secure financial structure.

Latest Report

View All
Consolidated Financial Results (Unaudited/Audited) for the Quarter and Year Ended March 31, 2026

Latest News

View All

Why Are Indians Dying Of Heart Attacks In Their 40s? Dr Arvind Lal Has Been Trying To Answer That For Decades

Overview
Ratio
Financial
Dr Lal Pathlabs Ltd Health Insights
Health Score : 8.79Health Score : 8.79

Dr Lal Pathlabs Ltd. demonstrates exceptional financial health, characterized by outstanding profitability and robust growth. The company is highly effective at turning revenue into profit and is expanding its earnings and sales at an impressive rate. Its financial foundation is remarkably strong, with very low reliance on debt, which minimizes financial risk. The company also maintains a very strong capacity to cover its immediate financial obligations. A key area of mixed performance is in its operational efficiency; while it manages its inventory and customer payments very effectively, it is not generating as much sales from its long-term assets as it could be. There is also a potential concern regarding the sustainability of its dividend payments, as earnings do not appear to fully cover them. Overall, the company's strong profitability and growth paint a positive picture, supported by a secure financial structure.

Latest Report

View All
Consolidated Financial Results (Unaudited/Audited) for the Quarter and Year Ended March 31, 2026

Latest News

View All

Why Are Indians Dying Of Heart Attacks In Their 40s? Dr Arvind Lal Has Been Trying To Answer That For Decades

Highly Overvalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Highly Overvalued

P/E RATIO (TTM)

53.95

Overvalued

Industry Median

31.45

Overvalued
Overvalued

Small Cap Median

31.45

Overvalued

P/E RATIO

54.29

P/B RATIO

10.91

Highly Overvalued

Industry Median

3.67

Highly Overvalued
Highly Overvalued

Small Cap Median

3.67

Highly Overvalued

P/S RATIO

9.95

Highly Overvalued

Industry Median

3.31

Highly Overvalued
Highly Overvalued

Small Cap Median

3.31

Highly Overvalued

Others

Overvalued

PEG RATIO

4.31

Overvalued
Overvalued

EV/EBITDA RATIO

31.35

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1635.8 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Quarterly Report30th Apr 26

Consolidated Financial Results (Unaudited/Audited) for the Quarter and Year Ended March 31, 2026

UNDEFINED SENTIMENT

Concall Report3rd Feb 26

Q3 FY26 Earnings Conference Call Transcript

NEUTRAL SENTIMENT

Concall Report31st Oct 25

Q2 H1 FY26 Earnings Conference Call Transcript

NEUTRAL SENTIMENT

Why Are Indians Dying Of Heart Attacks In Their 40s? Dr Arvind Lal Has Been Trying To Answer That For Decades

Impact

neutral

neutral

Sentiment

neutral

Category :

Healthcare Trends

Market Volatility :

low

Read Article

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company is experiencing a period of outstanding growth across all major financial dimensions. Revenues, profits, and earnings per share are all expanding at an excellent rate. This comprehensive growth indicates strong market demand for its services, successful business strategies, and effective management. The expansion of its asset base suggests continued investment to support future growth. This strong upward trajectory is a very positive sign for the company's future prospects and its ability to create value for shareholders.

AverageRevenue Growth RateAverage
AverageOperating Profit Growth RateAverage
GoodEarnings Per Share (EPS) GrowthGood
AverageAsset Growth RateAverage
AverageNet Income Growth RateAverage
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate32.01-3.3510.4110.5112.27
Operating Profit Growth Rate28.67-12.6624.2914.6112.03
Earnings Per Share (EPS) Growth18.3-30.7449.4836.043.4
Asset Growth Rate41.061.712.9810.5515.96
Net Income Growth Rate18.24-31.1450.2135.913.66
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 8.40

The company's financial metrics reflect strong performance in creating shareholder value. Key indicators like earnings per share and book value per share are at excellent levels, showing robust profitability and a solid equity base behind each share. However, the scoring model flags the company's high level of capital expenditures as a negative. While heavy investment can be essential for future growth in the healthcare sector, this model penalizes the high cash outflow, presenting a conflicting view of this strategic choice.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
ExcellentDividend Per Share (DPS)Excellent
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)42.7729.1644.2259.432.02
Cash Earnings Per Share (Cash EPS)55.1847.1160.9675.4840
Book Value Per Share180.84200.72222.77258.69149.35
Dividend Per Share (DPS)66.020024.41
Capital Expenditures (CapEx)474455653173
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company's profitability is outstanding across the board. It demonstrates a superior ability to convert revenue into profit at every level, from gross profit down to net income. Returns on equity, assets, and capital employed are all at excellent levels, indicating that management is highly effective at using the company's resources to generate profits. This high level of profitability is a core strength, providing the resources for growth, debt repayment, and returns to shareholders.

WeakGross Profit MarginWeak
ExcellentReturn on Capital Employed (ROCE)Excellent
GoodReturn on Equity (ROE)Good
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
GoodNet MarginGood
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin21.7116.8620.8822.5922.44
Return on Capital Employed (ROCE)2918252928
Return on Equity (ROE)23.3214.4719.5822.6420.33
Return on Assets (ROA)23.9420.5624.8225.7324.86
Operating Margin26.8824.2927.3528.3628.3
Net Margin16.7711.9516.2619.9918.46
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 7.33

The company's efficiency presents a mixed picture. On one hand, it is exceptionally efficient in managing its inventory and collecting payments from customers, indicating strong control over its working capital. This means products are sold quickly and cash is collected promptly. On the other hand, the company is not effectively using its fixed assets, like equipment and buildings, or its total capital to generate sales. This suggests that there are opportunities to derive more revenue from its substantial investments in infrastructure.

PoorFixed Asset Turnover RatioPoor
ExcellentInventory Turnover RatioExcellent
ExcellentReceivables Turnover RatioExcellent
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio1.521.551.812.112.2
Inventory Turnover Ratio34.0438.5549.6152.2253.55
Receivables Turnover Ratio27.4625.8630.0929.8327.77
Days Sales in Inventory Ratio10.729.477.366.996.82
Receivable Days13.2914.1112.1312.2413.14
Capital Turnover Ratio1.131.041.111.061.02
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

The company's ability to cover its financial obligations is a mixed story. On a positive note, its capacity to cover interest payments on its debt is exceptionally strong, thanks to its high earnings and low debt levels. This means there is virtually no risk of defaulting on its interest obligations. However, the company's ability to cover its dividend payments from its earnings appears weak. This suggests that the dividend policy may be aggressive relative to current profits, which could pose a risk to the sustainability of future dividend payouts.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio16.8310.0518.4129.4130.09
Equity Dividend Coverage Ratio3.452.381.23
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's solvency is in an exceptionally strong position. It relies very little on borrowed funds, with the vast majority of its assets being financed by owner's equity. This low level of debt translates to minimal financial risk and a very high capacity to withstand economic downturns. Creditors and investors would view this as a sign of supreme financial stability and long-term viability. The company is not burdened by significant interest payments, which frees up earnings for reinvestment or shareholder returns.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
PoorEquity RatioPoor
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.190.140.080.070.07
Debt to Equity Ratio0.230.160.090.080.08
Equity Ratio0.810.860.920.930.93
Debt To Asset Ratio0.150.110.070.060.06
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 9.60

The company exhibits an exceptionally strong liquidity position. It has a substantial cushion of cash and other liquid assets to meet its short-term financial obligations comfortably. This indicates a very low risk of facing a cash crunch in the near future. The ability to quickly convert assets into cash to pay off immediate debts is excellent. Cash generated from core business operations is also healthy and sufficient to cover its current liabilities, reinforcing its stable financial standing.

ExcellentCurrent RatioExcellent
ExcellentQuick RatioExcellent
ExcellentCash RatioExcellent
GoodOperating Cash Flow RatioGood
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.832.052.523.173.33
Quick Ratio1.721.982.433.083.23
Cash Ratio1.271.481.892.192.07
Operating Cash Flow Ratio0.921.011.221.491.45
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 3 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Dr Lal Pathlabs Ltd8.7954.29Highly Overvalued782.0030.32510.00
2Vijaya Diagnostic Centre Ltd8.4481.15Neutral337.0017.33173.00
3Indegene Ltd7.5831.98Neutral619.008.80401.00
Management Assessment Summary
OrangeBalanced Management

Dr. Lal Pathlabs' management demonstrates strong capabilities in operational efficiency and financial prudence, evidenced by consistently high operating margins, an outstanding negative cash conversion cycle, and a robust balance sheet with low, declining debt. Capital returns (ROCE/ROE) remain strong. However, the assessment is moderated to 'Orange' due to notable volatility in recent growth, with a significant profit decline in FY23 followed by a sharp recovery in FY24. Additionally, a long-term declining trend in ROCE from historical highs and a recent suspension of dividend payouts in FY24 (a departure from a consistent history) indicate areas of weakness or strategic shifts that temper the overall positive impression.

AverageFinancial Performance & GrowthAverage
GoodCapital Efficiency & ReturnsGood
ExcellentFinancial Health & PrudenceExcellent
ExcellentShareholding & Ownership StructureExcellent
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The overall risk profile for Dr. Lal Pathlabs is moderate. Financial and accounting risks are minimal due to a very strong balance sheet, low debt, and high-quality earnings, as evidenced by strong cash flow conversion. However, the primary risk identified is significant business performance volatility. The sharp fluctuations in sales and profit growth in recent years create uncertainty around the company's future earnings trajectory. While the solid financial foundation provides a buffer against this volatility, the unpredictability in core business performance is a notable concern.

WeakBusiness Performance RiskWeak
ExcellentFinancial RiskExcellent
ExcellentAccounting QualityExcellent
01.

Business Performance Risk

02.

Financial Risk

03.

Accounting Quality

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101646.54Bearish
  3. SMA 201647.86Bearish
  4. SMA 501632.99Bullish
  5. EMA 101642.46Bearish
  6. EMA 201644.91Bearish
  7. EMA 501632.66Bullish
  8. DEMA 101637.11Bullish
  9. DEMA 201646.40Bearish
  10. DEMA 501654.73Bearish
  11. TEMA 101634.40Bullish
  12. TEMA 201636.69Bullish
  13. TEMA 501662.23Bearish
  14. MACD-0.11Bearish
  15. ADX19.95Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI47.87Neutral
  3. CCI-99.11Neutral
  4. ROC 9-1.03Bearish
  5. ROC 14-0.67Bearish
  6. ROC 25-3.56Bearish
  7. Stoch K21.83Neutral
  8. Stoch D17.39Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1667.24Neutral
  3. BB Middle1647.86Neutral
  4. BB Lower1628.48Neutral
  5. ATR19.73Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI48.93Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101646.95Bearish
  3. SMA 201648.35Bearish
  4. SMA 501601.32Bullish
  5. EMA 101644.80Bearish
  6. EMA 201639.25Bearish
  7. EMA 501619.14Bullish
  8. DEMA 101644.49Bearish
  9. DEMA 201655.58Bearish
  10. DEMA 501641.19Bearish
  11. TEMA 101637.07Bullish
  12. TEMA 201652.52Bearish
  13. TEMA 501650.11Bearish
  14. MACD10.49Bearish
  15. ADX42.45Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI51.19Neutral
  3. CCI-39.92Neutral
  4. ROC 9-0.96Bearish
  5. ROC 14-3.67Bearish
  6. ROC 252.41Bullish
  7. Stoch K12.61Oversold
  8. Stoch D14.52Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1723.71Neutral
  3. BB Middle1648.35Neutral
  4. BB Lower1572.99Neutral
  5. ATR29.32Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI19.77Oversold

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101644.26Bearish
  3. SMA 201609.75Bullish
  4. SMA 501610.63Bullish
  5. EMA 101636.08Bullish
  6. EMA 201621.10Bullish
  7. EMA 501594.51Bullish
  8. DEMA 101651.69Bearish
  9. DEMA 201642.34Bearish
  10. DEMA 501646.39Bearish
  11. TEMA 101649.42Bearish
  12. TEMA 201654.31Bearish
  13. TEMA 50N/AN/A
  14. MACD17.27Bullish
  15. ADX41.80Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI55.20Neutral
  3. CCI39.43Neutral
  4. ROC 92.08Bullish
  5. ROC 144.71Bullish
  6. ROC 254.11Bullish
  7. Stoch K35.52Neutral
  8. Stoch D37.37Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1692.39Neutral
  3. BB Middle1609.75Neutral
  4. BB Lower1527.10Neutral
  5. ATR43.04Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI77.28Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 101609.39Bullish
  3. SMA 201598.67Bullish
  4. SMA 501543.17Bullish
  5. SMA 1001463.31Bullish
  6. SMA 2001500.78Bullish
  7. EMA 101620.86Bullish
  8. EMA 201603.73Bullish
  9. EMA 501552.29Bullish
  10. EMA 1001510.18Bullish
  11. EMA 2001489.98Bullish
  12. DEMA 101641.40Bearish
  13. DEMA 201635.04Bullish
  14. DEMA 501622.61Bullish
  15. DEMA 1001552.73Bullish
  16. DEMA 2001513.66Bullish
  17. TEMA 101652.98Bearish
  18. TEMA 201629.56Bullish
  19. TEMA 501657.87Bearish
  20. TEMA 1001601.89Bullish
  21. TEMA 2001518.32Bullish
  22. MACD23.45Bullish
  23. ADX25.85Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI58.22Neutral
  3. CCI86.18Neutral
  4. ROC 143.71Bullish
  5. ROC 252.23Bullish
  6. Stoch K49.54Neutral
  7. Stoch D53.30Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1668.51Neutral
  3. BB Middle1598.67Neutral
  4. BB Lower1528.84Neutral
  5. ATR61.53Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI83.01Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 201448.14Bullish
  3. SMA 501502.32Bullish
  4. EMA 201492.27Bullish
  5. EMA 501473.42Bullish
  6. DEMA 201528.61Bullish
  7. DEMA 501493.27Bullish
  8. TEMA 201575.32Bullish
  9. TEMA 501482.40Bullish
  10. MACD35.61Bullish
  11. ADX20.59Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI57.00Neutral
  3. CCI52.41Neutral
  4. ROC 1417.76Bullish
  5. ROC 2515.08Bullish
  6. Stoch K69.16Neutral
  7. Stoch D72.64Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1666.84Neutral
  3. BB Middle1448.13Neutral
  4. BB Lower1229.43Neutral
  5. ATR103.13High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI78.39Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 61429.78Bullish
  3. SMA 121488.29Bullish
  4. SMA 241471.35Bullish
  5. EMA 61461.93Bullish
  6. EMA 121456.49Bullish
  7. EMA 241429.00Bullish
  8. DEMA 61471.89Bullish
  9. DEMA 121470.53Bullish
  10. DEMA 241494.74Bullish
  11. TEMA 61492.11Bullish
  12. TEMA 121454.89Bullish
  13. TEMA 241480.31Bullish
  14. MACD107.68Bearish
  15. ADX20.17Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI56.34Neutral
  3. CCI105.41Overbought
  4. ROC 2535.50Bullish
  5. ROC 5023.14Bullish
  6. Stoch K54.20Neutral
  7. Stoch D59.13Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1697.16Neutral
  3. BB Middle1450.83Neutral
  4. BB Lower1204.50Neutral
  5. ATR191.98High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI60.44Neutral